- Home
- ANEB vs FRSX Comparison
ANEB vs FRSX Comparison
Compare ANEB & FRSX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ANEB
- FRSX
- Stock Information
- Founded
- ANEB 2020
- FRSX N/A
- Country
- ANEB United States
- FRSX Israel
- Employees
- ANEB N/A
- FRSX N/A
- Industry
- ANEB Biotechnology: Pharmaceutical Preparations
- FRSX Computer Software: Prepackaged Software
- Sector
- ANEB Health Care
- FRSX Technology
- Exchange
- ANEB Nasdaq
- FRSX Nasdaq
- Market Cap
- ANEB 111.8M
- FRSX 7.1M
- IPO Year
- ANEB 2021
- FRSX 2017
- Fundamental
- Price
- ANEB $2.53
- FRSX $2.22
- Analyst Decision
- ANEB Buy
- FRSX
- Analyst Count
- ANEB 2
- FRSX 0
- Target Price
- ANEB $8.00
- FRSX N/A
- AVG Volume (30 Days)
- ANEB 21.4K
- FRSX 53.3K
- Earning Date
- ANEB 11-14-2025
- FRSX 11-28-2025
- Dividend Yield
- ANEB N/A
- FRSX N/A
- EPS Growth
- ANEB N/A
- FRSX N/A
- EPS
- ANEB N/A
- FRSX N/A
- Revenue
- ANEB N/A
- FRSX $452,000.00
- Revenue This Year
- ANEB N/A
- FRSX N/A
- Revenue Next Year
- ANEB N/A
- FRSX N/A
- P/E Ratio
- ANEB N/A
- FRSX N/A
- Revenue Growth
- ANEB N/A
- FRSX N/A
- 52 Week Low
- ANEB $0.80
- FRSX $1.98
- 52 Week High
- ANEB $3.42
- FRSX $18.41
- Technical
- Relative Strength Index (RSI)
- ANEB 48.02
- FRSX 49.61
- Support Level
- ANEB $2.50
- FRSX $2.21
- Resistance Level
- ANEB $2.76
- FRSX $2.58
- Average True Range (ATR)
- ANEB 0.12
- FRSX 0.15
- MACD
- ANEB -0.01
- FRSX -0.04
- Stochastic Oscillator
- ANEB 41.82
- FRSX 12.00
About ANEB Anebulo Pharmaceuticals Inc.
Anebulo Pharmaceuticals Inc is a clinical-stage biotechnology company focused on developing treatments for cannabinoid overdose and substance addiction. Its principal product candidate, ANEB-001 (Selonabant), is designed to rapidly counteract the negative effects of cannabis toxicity, including unintentional cannabis poisoning and acute cannabinoid intoxication. The company is focusing on addressing the unmet medical needs in the treatment of cannabinoid toxicity through various therapies. Anebulo Pharmaceuticals operates in one segment, exclusively in the United States.
About FRSX Foresight Autonomous Holdings Ltd.
Foresight Autonomous Holdings Ltd is a technology company engaged in the design, development and commercialization of vision systems for the automotive industry. The company develops both in-line-of-sight vision systems and beyond-line-of-sight cellular-based applications through its wholly-owned subsidiaries. Its systems are designed to improve driving safety by enabling accurate and reliable threat detection while ensuring the lowest rates of false alerts. Foresight is pursuing several markets and believes its modern systems will revolutionize automotive safety by providing an automotive-grade, cost-effective platform.